vimarsana.com
Home
Live Updates
BD Reports Second Quarter Fiscal 2024 Financial Results : comparemela.com
BD Reports Second Quarter Fiscal 2024 Financial Results
Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024
Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organicQ2 GAAP and...
Related Keywords
United States ,
China ,
Singapore ,
Russia ,
Ukraine ,
America ,
Tom Polen ,
Troy Kirkpatrick ,
Exchange Commission ,
Bd Life Sciences ,
Medication Delivery Solutions ,
Camtech Health ,
Business Group On Health ,
Linkedin ,
Medication Management Solutions ,
Diagnostics Solutions ,
America Most Innovative Companies ,
Clinical Solutions ,
European Union Medical Device Regulation ,
Margin Execution Drives Better Performance ,
Higher Guidance ,
Continuing Operations ,
Free Cash Flow ,
Corporate Sustainability ,
Automated Dispensing Cabinet ,
Integrated Diagnostics Solutions ,
Peripheral Intervention ,
Covered Stent ,
Peripheral Arterial ,
Most Innovative Companies ,
Best Employer ,
Employee Well Being ,
Business Group ,
Quarter Fiscal ,
Diluted Earnings ,
Months Ended March ,
Pharmaceutical Systems ,
Vascular Access Management ,
Infusion System ,
Pharmacy Automation ,
Integrated Diagnostic Solutions ,
Blood Culture ,
Clinical Reagents ,
Clinical Cell Analyzer ,
Sample Preparation System ,
Critical Care ,
Infection Prevention ,
Surgical Instrumentation ,
Peripheral Vascular Disease ,
Atherectomy System ,
Full Year Fiscal ,
Revenue Growth ,
Surgical Instrumentation Platform ,
Foreign Currency Impact ,
Adjusted Diluted ,
Devices Regulations ,
Middle East ,
Adam Reiffe ,
Investor Relations ,
Public Relations ,
Cash Provided ,
Continuing Operating ,
Diabetes Care ,
Foreign Currency ,
Share Percentage ,
Markets ,
comparemela.com © 2020. All Rights Reserved.